Endometriosis: Molecular Pathophysiology and Recent Treatment Strategies-Comprehensive Literature Review

被引:3
作者
Sadlocha, Marcin [1 ]
Toczek, Jakub [1 ]
Major, Katarzyna [2 ]
Staniczek, Jakub [1 ]
Stojko, Rafal [1 ]
机构
[1] Med Univ Silesia, Dept Gynecol Obstet & Oncol Gynecol, Markiefki 87, PL-40211 Katowice, Poland
[2] Municipal Hosp Ruda Slaska, Dept Neonatol, Wincentego Lipa 2, PL-41703 Ruda Slaska, Poland
关键词
endometriosis; clinical diagnosis; pharmacological treatment; estrogen; REGULATORY T-CELLS; PERITONEAL-FLUID; OXIDATIVE STRESS; WOMEN; PATHOGENESIS; EXPRESSION; INFERTILITY; ESTROGEN; PAIN; PROLIFERATION;
D O I
10.3390/ph17070827
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Endometriosis is an enigmatic disease, with no specific cause or trigger yet discovered. Major factors that may contribute to endometriosis in the pelvic region include environmental, epigenetic, and inflammatory factors. Most experts believe that the primary mechanism behind the formation of endometrial lesions is associated with Sampson's theory of "retrograde menstruation". This theory suggests that endometrial cells flow backward into the peritoneal cavity, leading to the development of endometrial lesions. Since this specific mechanism is also observed in healthy women, additional factors may be associated with the formation of endometrial lesions. Current treatment options primarily consist of medical or surgical therapies. To date, none of the available medical therapies have proven effective in curing the disorder, and symptoms tend to recur once medications are discontinued. Therefore, there is a need to explore and develop novel biomedical targets aimed at the cellular and molecular mechanisms responsible for endometriosis growth. This article discusses a recent molecular pathophysiology associated with the formation and progression of endometriosis. Furthermore, the article summarizes the most current medications and surgical strategies currently under investigation for the treatment of endometriosis.
引用
收藏
页数:15
相关论文
共 114 条
[1]  
Adams ED, 2024, JOGNN-J OBST GYN NEO, V53, P590, DOI [10.1016/S0140-6736(22)00622-5, 10.1016/j.jogn.2024.09.009]
[2]   Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back [J].
Agarwal, Sanjay K. ;
Foster, Andwarren G. .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[3]  
Alimi Yusuf, 2018, Cureus, V10, pe3361, DOI 10.7759/cureus.3361
[4]  
[Anonymous], ABOUT US
[5]  
As-Sanie S, 2020, FERTIL STERIL, V114, pE77
[6]   Anatomic distribution of endometriosis: A reappraisal based on series of 1101 patients [J].
Audebert, A. ;
Petousis, S. ;
Margioula-Siarkou, C. ;
Ravanos, K. ;
Prapas, N. ;
Prapas, Y. .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 230 :36-40
[7]   Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease [J].
Bacci, Monica ;
Capobianco, Annalisa ;
Monno, Antonella ;
Cottone, Lucia ;
Di Puppo, Francesca ;
Camisa, Barbara ;
Mariani, Margherita ;
Brignole, Chiara ;
Ponzoni, Mirco ;
Ferrari, Stefano ;
Panina-Bordignon, Paola ;
Manfredi, Angelo A. ;
Rovere-Querini, Patrizia .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (02) :547-556
[8]   Laparoscopic surgery for endometriosis [J].
Bafort, Celine ;
Beebeejaun, Yusuf ;
Tomassetti, Carla ;
Bosteels, Jan ;
Duffy, James M. N. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (10)
[9]   Value of thin-section oblique axial T2-weighted magnetic resonance images to assess uterosacral ligament endometriosis [J].
Bazot, Marc ;
Gasner, Adeline ;
Ballester, Marcos ;
Darai, Emile .
HUMAN REPRODUCTION, 2011, 26 (02) :346-353
[10]   New developments in the medical treatment of endometriosis [J].
Bedaiwy, Mohamed A. ;
Alfaraj, Sukinah ;
Yong, Paul ;
Casper, Robert .
FERTILITY AND STERILITY, 2017, 107 (03) :555-565